Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
A combination dietary supplement consisting of **myo-inositol, d-chiro-inositol, folic acid, vitamin D, and vitamin B12**. This formulation is most commonly used for **supporting women’s reproductive health**, especially for the management of **polycystic ovary syndrome (PCOS)**, regulation of menstrual cycles, improvement of ovulation and fertility, and metabolic support. Myo-inositol and d-chiro-inositol act as insulin sensitizers and contribute to hormonal balance and ovarian function. Folic acid (often in the active l-methylfolate form) supports DNA synthesis and fetal development, while vitamin D is important for hormonal and immune modulation, and vitamin B12 supports neural function and prevents deficiency, especially important in populations at risk due to other medications (e.g., metformin in PCOS). These components are typically available as oral tablets, capsules, or powder sachets. This combination is not a pharmaceutical drug but a dietary supplement, and is sold under various formulations by multiple manufacturers, primarily targeting women with PCOS and related metabolic or fertility concerns[1][2][3][4][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on myo-inositol + d-chiro-inositol + folic acid + vitamin d + vitamin b12.